Corrections:

Mohamed A. Ahmed^1,2, Edgar Selzer³, Wolfgang Dörr^3,4, Gerd Jomrich⁵, Felix Harpain⁵, Gerd R. Silberhumer⁵, Leonhard Müllauer⁶, Klaus Holzmann¹, Bettina Grasl-Kraupp¹, Michael Grusch¹, Walter Berger¹, Brigitte Marian¹

¹ Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria
² Radiation Biology Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Egypt
³ Department of Radiotherapy and Radiobiology, Medical University of Vienna, Austria
⁴ Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria
⁵ Department of Surgery, Medical University Vienna, Austria
⁶ Clinical Institute of Pathology, Medical University Vienna, Austria

Published: September 03, 2019

This article has been corrected: While analyzing the same patient cohort for different markers, the authors realized a mistake in Table 2. The table reports on the correlation of radiation therapy response and FGFR4 immunoreactivity score. For both data sets, the stratification criteria were more stringent than mentioned in the table. However, the numerical results reported in the table were re-checked and found to be correct. The corrected Table 2 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2016; 7:60885–60895. DOI: https://doi.org/10.18632/oncotarget.12099.